Showing 1 - 7 results of 7 for search 'Changbin Zhu', query time: 0.04s Refine Results
  1. 1
    Reliability and Validity of the Chinese Version Appropriateness Evaluation Protocol.

    Reliability and Validity of the Chinese Version Appropriateness Evaluation Protocol. by Wenwei Liu, Suwei Yuan, Fengqing Wei, Jing Yang, Zhe Zhang, Changbin Zhu, Jin Ma

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis

    Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis by Qunxian Rao, Jianwei Liao, Yangyang Li, Xin Zhang, Guocai Xu, Changbin Zhu, Shengya Tian, Qiuhong Chen, Hui Zhou, Bingzhong Zhang

    Published 2023-03-01
    Get full text
    Article
  3. 3
    COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy

    COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy by Jian‐Hua Liu, Ju‐Ze Lin, Qianhui Qiu, Changbin Zhu, Weiwei Li, Qian Li, Zhan Huang, Xueer Xia, Guibin Qiao, Jiming Tang

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma

    Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma by Yuxiang Ma, Huaqiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao

    Published 2024-03-01
    Get full text
    Article
  5. 5
    Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions

    Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions by Yuan Qiu, Yuan Qiu, Liping Liu, Liping Liu, Haihong Yang, Haihong Yang, Hanzhang Chen, Hanzhang Chen, Qiuhua Deng, Qiuhua Deng, Dakai Xiao, Dakai Xiao, Yongping Lin, Yongping Lin, Changbin Zhu, Weiwei Li, Di Shao, Wenxi Jiang, Kui Wu, Jianxing He, Jianxing He

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

    Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phas... by Wei Huang, Yan Zhang, Hui Zhu, Xiao Han, Yingjie Zhang, Jun Guo, Linlin Wang, Ying Hua, Xiangjiao Meng, Zhehai Wang, Xiaoyong Tang, Dongyuan Zhu, Xiqin Zhang, Zhongtang Wang, Shuanghu Yuan, Pinliang Zhang, Heyi Gong, Yulan Sun, Zengjun Liu, Xiaomeng Dong, Fei Gai, Zhan Huang, Changbin Zhu

    Published 2022-12-01
    Get full text
    Article
  7. 7
    Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer

    Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer by Yuan Qiu, Yuan Qiu, Liping Liu, Liping Liu, Liping Liu, Haihong Yang, Haihong Yang, Hanzhang Chen, Hanzhang Chen, Qiuhua Deng, Qiuhua Deng, Dakai Xiao, Dakai Xiao, Yongping Lin, Yongping Lin, Changbin Zhu, Weiwei Li, Di Shao, Wenxi Jiang, Kui Wu, Kui Wu, Kui Wu, Jianxing He, Jianxing He

    Published 2021-04-01
    Get full text
    Article

Search Tools: